Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P6
Near historical low
vs 2Y Ago
-161.4x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -526.92% |
| Q3 2025 | 7.75% |
| Q2 2025 | 118.57% |
| Q1 2025 | 28.75% |
| Q4 2024 | 44.89% |
| Q3 2024 | -36.16% |
| Q2 2024 | 18.24% |
| Q1 2024 | 19.61% |
| Q4 2023 | 3.27% |
| Q3 2023 | -105.90% |
| Q2 2023 | -63.86% |
| Q1 2023 | -14.14% |
| Q4 2022 | -528.94% |
| Q3 2022 | 115.88% |
| Q2 2022 | -23.09% |
| Q1 2022 | 12.51% |
| Q4 2021 | 28.03% |
| Q3 2021 | -9.66% |
| Q2 2021 | -17985.00% |
| Q1 2021 | 100.50% |
| Q4 2020 | -24.86% |
| Q3 2020 | -11.66% |
| Q2 2020 | 12.64% |
| Q1 2020 | -23.65% |
| Q4 2019 | -22.12% |
| Q3 2019 | 13.00% |
| Q2 2019 | 6.29% |
| Q1 2019 | 1.98% |
| Q4 2018 | -14.28% |
| Q3 2018 | -17.23% |
| Q2 2018 | -219.16% |
| Q1 2018 | -33.54% |
| Q4 2017 | -5.60% |
| Q3 2017 | -24.02% |
| Q2 2017 | -92.11% |
| Q1 2017 | 0.00% |